Global Factor Xa Inhibitors Supply, Demand and Key Producers, 2024-2030

Description

Factor Xa inhibitors are anticoagulant drugs that block factor Xa, an enzyme crucial in the blood clotting process, thereby preventing clot formation. They are used to treat and prevent conditions like deep vein thrombosis, pulmonary embolism, and atrial fibrillation.

The global Factor Xa Inhibitors market size is expected to reach $ 33430 million by 2030, rising at a market growth of 5.7% CAGR during the forecast period (2024-2030).

The market for Factor Xa inhibitors has been expanding steadily due to their advantages over traditional anticoagulants. Drugs like rivaroxaban, apixaban, and edoxaban are increasingly preferred for their ease of use, predictable dosing, and minimal need for routine monitoring. This shift has been driven by the need for more convenient and effective treatments for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).

Competition in the Factor Xa inhibitors market is growing as pharmaceutical companies continue to develop and launch new products with improved formulations. Efforts are focused on expanding the indications of these drugs, optimizing dosing regimens, and enhancing patient adherence. This competitive landscape is fostering innovation and leading to a wider range of options available to healthcare providers and patients.

However, the market faces challenges including high drug costs and the introduction of alternative therapies. Regulatory scrutiny and evolving treatment guidelines also impact market dynamics. Despite these challenges, ongoing advancements and research are expected to drive continued growth and development in the Factor Xa inhibitors market.

This report studies the global Factor Xa Inhibitors production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Factor Xa Inhibitors and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Factor Xa Inhibitors that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Factor Xa Inhibitors total production and demand, 2019-2030, (K Units)
Global Factor Xa Inhibitors total production value, 2019-2030, (USD Million)
Global Factor Xa Inhibitors production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units), (based on production site)
Global Factor Xa Inhibitors consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Factor Xa Inhibitors domestic production, consumption, key domestic manufacturers and share
Global Factor Xa Inhibitors production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Factor Xa Inhibitors production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Factor Xa Inhibitors production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
This report profiles key players in the global Factor Xa Inhibitors market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bristol Myers Squibb, Daiichi Sankyo, Janssen Pharmaceuticals, Bayer, Viatris, Dr. Reddy's Laboratories, GlaxoSmithKline, Eugia Pharma, Accord Healthcare, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Factor Xa Inhibitors market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Factor Xa Inhibitors Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Factor Xa Inhibitors Market, Segmentation by Type:
    Oral Drugs
    Injections

Global Factor Xa Inhibitors Market, Segmentation by Application:
    Deep Vein Thrombosis
    Pulmonary Embolism
    Atrial Fibrillation
    Other

Companies Profiled:
    Pfizer
    Bristol Myers Squibb
    Daiichi Sankyo
    Janssen Pharmaceuticals
    Bayer
    Viatris
    Dr. Reddy's Laboratories
    GlaxoSmithKline
    Eugia Pharma
    Accord Healthcare
    Apotex
    Zydus
    Lupin
    Jiangsu Hengrui Pharmaceuticals
    Cspc Ouyi Pharmaceutical
    Zhejiang Hisun Pharmaceutical
    Hansoh Pharma
    Chia Tai Tianqing Pharmaceutical
    Shanghai Huilun Pharmaceutical
    Qilu Pharmaceutical
    HEC Pharma
    BrightGene
    Kelun Pharmaceutical
    Nanjing King-Friend Biochemical Pharmaceutical

Key Questions Answered:
1. How big is the global Factor Xa Inhibitors market?
2. What is the demand of the global Factor Xa Inhibitors market?
3. What is the year over year growth of the global Factor Xa Inhibitors market?
4. What is the production and production value of the global Factor Xa Inhibitors market?
5. Who are the key producers in the global Factor Xa Inhibitors market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Factor Xa Inhibitors Introduction
    1.2 World Factor Xa Inhibitors Supply & Forecast
        1.2.1 World Factor Xa Inhibitors Production Value (2019 & 2023 & 2030)
        1.2.2 World Factor Xa Inhibitors Production (2019-2030)
        1.2.3 World Factor Xa Inhibitors Pricing Trends (2019-2030)
    1.3 World Factor Xa Inhibitors Production by Region (Based on Production Site)
        1.3.1 World Factor Xa Inhibitors Production Value by Region (2019-2030)
        1.3.2 World Factor Xa Inhibitors Production by Region (2019-2030)
        1.3.3 World Factor Xa Inhibitors Average Price by Region (2019-2030)
        1.3.4 North America Factor Xa Inhibitors Production (2019-2030)
        1.3.5 Europe Factor Xa Inhibitors Production (2019-2030)
        1.3.6 China Factor Xa Inhibitors Production (2019-2030)
        1.3.7 Japan Factor Xa Inhibitors Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Factor Xa Inhibitors Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Factor Xa Inhibitors Major Market Trends

2 Demand Summary
    2.1 World Factor Xa Inhibitors Demand (2019-2030)
    2.2 World Factor Xa Inhibitors Consumption by Region
        2.2.1 World Factor Xa Inhibitors Consumption by Region (2019-2024)
        2.2.2 World Factor Xa Inhibitors Consumption Forecast by Region (2025-2030)
    2.3 United States Factor Xa Inhibitors Consumption (2019-2030)
    2.4 China Factor Xa Inhibitors Consumption (2019-2030)
    2.5 Europe Factor Xa Inhibitors Consumption (2019-2030)
    2.6 Japan Factor Xa Inhibitors Consumption (2019-2030)
    2.7 South Korea Factor Xa Inhibitors Consumption (2019-2030)
    2.8 ASEAN Factor Xa Inhibitors Consumption (2019-2030)
    2.9 India Factor Xa Inhibitors Consumption (2019-2030)

3 World Manufacturers Competitive Analysis
    3.1 World Factor Xa Inhibitors Production Value by Manufacturer (2019-2024)
    3.2 World Factor Xa Inhibitors Production by Manufacturer (2019-2024)
    3.3 World Factor Xa Inhibitors Average Price by Manufacturer (2019-2024)
    3.4 Factor Xa Inhibitors Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Factor Xa Inhibitors Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Factor Xa Inhibitors in 2023
        3.5.3 Global Concentration Ratios (CR8) for Factor Xa Inhibitors in 2023
    3.6 Factor Xa Inhibitors Market: Overall Company Footprint Analysis
        3.6.1 Factor Xa Inhibitors Market: Region Footprint
        3.6.2 Factor Xa Inhibitors Market: Company Product Type Footprint
        3.6.3 Factor Xa Inhibitors Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Factor Xa Inhibitors Production Value Comparison
        4.1.1 United States VS China: Factor Xa Inhibitors Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Factor Xa Inhibitors Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Factor Xa Inhibitors Production Comparison
        4.2.1 United States VS China: Factor Xa Inhibitors Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Factor Xa Inhibitors Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Factor Xa Inhibitors Consumption Comparison
        4.3.1 United States VS China: Factor Xa Inhibitors Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Factor Xa Inhibitors Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Factor Xa Inhibitors Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Factor Xa Inhibitors Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Factor Xa Inhibitors Production (2019-2024)
    4.5 China Based Factor Xa Inhibitors Manufacturers and Market Share
        4.5.1 China Based Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Factor Xa Inhibitors Production Value (2019-2024)
        4.5.3 China Based Manufacturers Factor Xa Inhibitors Production (2019-2024)
    4.6 Rest of World Based Factor Xa Inhibitors Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Factor Xa Inhibitors Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Factor Xa Inhibitors Production (2019-2024)

5 Market Analysis by Type
    5.1 World Factor Xa Inhibitors Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Oral Drugs
        5.2.2 Injections
    5.3 Market Segment by Type
        5.3.1 World Factor Xa Inhibitors Production by Type (2019-2030)
        5.3.2 World Factor Xa Inhibitors Production Value by Type (2019-2030)
        5.3.3 World Factor Xa Inhibitors Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Factor Xa Inhibitors Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Deep Vein Thrombosis
        6.2.2 Pulmonary Embolism
        6.2.3 Atrial Fibrillation
        6.2.4 Other
    6.3 Market Segment by Application
        6.3.1 World Factor Xa Inhibitors Production by Application (2019-2030)
        6.3.2 World Factor Xa Inhibitors Production Value by Application (2019-2030)
        6.3.3 World Factor Xa Inhibitors Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Details
        7.1.2 Pfizer Major Business
        7.1.3 Pfizer Factor Xa Inhibitors Product and Services
        7.1.4 Pfizer Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Pfizer Recent Developments/Updates
        7.1.6 Pfizer Competitive Strengths & Weaknesses
    7.2 Bristol Myers Squibb
        7.2.1 Bristol Myers Squibb Details
        7.2.2 Bristol Myers Squibb Major Business
        7.2.3 Bristol Myers Squibb Factor Xa Inhibitors Product and Services
        7.2.4 Bristol Myers Squibb Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Bristol Myers Squibb Recent Developments/Updates
        7.2.6 Bristol Myers Squibb Competitive Strengths & Weaknesses
    7.3 Daiichi Sankyo
        7.3.1 Daiichi Sankyo Details
        7.3.2 Daiichi Sankyo Major Business
        7.3.3 Daiichi Sankyo Factor Xa Inhibitors Product and Services
        7.3.4 Daiichi Sankyo Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Daiichi Sankyo Recent Developments/Updates
        7.3.6 Daiichi Sankyo Competitive Strengths & Weaknesses
    7.4 Janssen Pharmaceuticals
        7.4.1 Janssen Pharmaceuticals Details
        7.4.2 Janssen Pharmaceuticals Major Business
        7.4.3 Janssen Pharmaceuticals Factor Xa Inhibitors Product and Services
        7.4.4 Janssen Pharmaceuticals Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 Janssen Pharmaceuticals Recent Developments/Updates
        7.4.6 Janssen Pharmaceuticals Competitive Strengths & Weaknesses
    7.5 Bayer
        7.5.1 Bayer Details
        7.5.2 Bayer Major Business
        7.5.3 Bayer Factor Xa Inhibitors Product and Services
        7.5.4 Bayer Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Bayer Recent Developments/Updates
        7.5.6 Bayer Competitive Strengths & Weaknesses
    7.6 Viatris
        7.6.1 Viatris Details
        7.6.2 Viatris Major Business
        7.6.3 Viatris Factor Xa Inhibitors Product and Services
        7.6.4 Viatris Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Viatris Recent Developments/Updates
        7.6.6 Viatris Competitive Strengths & Weaknesses
    7.7 Dr. Reddy's Laboratories
        7.7.1 Dr. Reddy's Laboratories Details
        7.7.2 Dr. Reddy's Laboratories Major Business
        7.7.3 Dr. Reddy's Laboratories Factor Xa Inhibitors Product and Services
        7.7.4 Dr. Reddy's Laboratories Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 Dr. Reddy's Laboratories Recent Developments/Updates
        7.7.6 Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
    7.8 GlaxoSmithKline
        7.8.1 GlaxoSmithKline Details
        7.8.2 GlaxoSmithKline Major Business
        7.8.3 GlaxoSmithKline Factor Xa Inhibitors Product and Services
        7.8.4 GlaxoSmithKline Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 GlaxoSmithKline Recent Developments/Updates
        7.8.6 GlaxoSmithKline Competitive Strengths & Weaknesses
    7.9 Eugia Pharma
        7.9.1 Eugia Pharma Details
        7.9.2 Eugia Pharma Major Business
        7.9.3 Eugia Pharma Factor Xa Inhibitors Product and Services
        7.9.4 Eugia Pharma Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 Eugia Pharma Recent Developments/Updates
        7.9.6 Eugia Pharma Competitive Strengths & Weaknesses
    7.10 Accord Healthcare
        7.10.1 Accord Healthcare Details
        7.10.2 Accord Healthcare Major Business
        7.10.3 Accord Healthcare Factor Xa Inhibitors Product and Services
        7.10.4 Accord Healthcare Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 Accord Healthcare Recent Developments/Updates
        7.10.6 Accord Healthcare Competitive Strengths & Weaknesses
    7.11 Apotex
        7.11.1 Apotex Details
        7.11.2 Apotex Major Business
        7.11.3 Apotex Factor Xa Inhibitors Product and Services
        7.11.4 Apotex Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Apotex Recent Developments/Updates
        7.11.6 Apotex Competitive Strengths & Weaknesses
    7.12 Zydus
        7.12.1 Zydus Details
        7.12.2 Zydus Major Business
        7.12.3 Zydus Factor Xa Inhibitors Product and Services
        7.12.4 Zydus Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Zydus Recent Developments/Updates
        7.12.6 Zydus Competitive Strengths & Weaknesses
    7.13 Lupin
        7.13.1 Lupin Details
        7.13.2 Lupin Major Business
        7.13.3 Lupin Factor Xa Inhibitors Product and Services
        7.13.4 Lupin Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.13.5 Lupin Recent Developments/Updates
        7.13.6 Lupin Competitive Strengths & Weaknesses
    7.14 Jiangsu Hengrui Pharmaceuticals
        7.14.1 Jiangsu Hengrui Pharmaceuticals Details
        7.14.2 Jiangsu Hengrui Pharmaceuticals Major Business
        7.14.3 Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Product and Services
        7.14.4 Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.14.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
        7.14.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
    7.15 Cspc Ouyi Pharmaceutical
        7.15.1 Cspc Ouyi Pharmaceutical Details
        7.15.2 Cspc Ouyi Pharmaceutical Major Business
        7.15.3 Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Product and Services
        7.15.4 Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.15.5 Cspc Ouyi Pharmaceutical Recent Developments/Updates
        7.15.6 Cspc Ouyi Pharmaceutical Competitive Strengths & Weaknesses
    7.16 Zhejiang Hisun Pharmaceutical
        7.16.1 Zhejiang Hisun Pharmaceutical Details
        7.16.2 Zhejiang Hisun Pharmaceutical Major Business
        7.16.3 Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Product and Services
        7.16.4 Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.16.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
        7.16.6 Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses
    7.17 Hansoh Pharma
        7.17.1 Hansoh Pharma Details
        7.17.2 Hansoh Pharma Major Business
        7.17.3 Hansoh Pharma Factor Xa Inhibitors Product and Services
        7.17.4 Hansoh Pharma Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.17.5 Hansoh Pharma Recent Developments/Updates
        7.17.6 Hansoh Pharma Competitive Strengths & Weaknesses
    7.18 Chia Tai Tianqing Pharmaceutical
        7.18.1 Chia Tai Tianqing Pharmaceutical Details
        7.18.2 Chia Tai Tianqing Pharmaceutical Major Business
        7.18.3 Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Product and Services
        7.18.4 Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.18.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
        7.18.6 Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
    7.19 Shanghai Huilun Pharmaceutical
        7.19.1 Shanghai Huilun Pharmaceutical Details
        7.19.2 Shanghai Huilun Pharmaceutical Major Business
        7.19.3 Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Product and Services
        7.19.4 Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.19.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
        7.19.6 Shanghai Huilun Pharmaceutical Competitive Strengths & Weaknesses
    7.20 Qilu Pharmaceutical
        7.20.1 Qilu Pharmaceutical Details
        7.20.2 Qilu Pharmaceutical Major Business
        7.20.3 Qilu Pharmaceutical Factor Xa Inhibitors Product and Services
        7.20.4 Qilu Pharmaceutical Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.20.5 Qilu Pharmaceutical Recent Developments/Updates
        7.20.6 Qilu Pharmaceutical Competitive Strengths & Weaknesses
    7.21 HEC Pharma
        7.21.1 HEC Pharma Details
        7.21.2 HEC Pharma Major Business
        7.21.3 HEC Pharma Factor Xa Inhibitors Product and Services
        7.21.4 HEC Pharma Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.21.5 HEC Pharma Recent Developments/Updates
        7.21.6 HEC Pharma Competitive Strengths & Weaknesses
    7.22 BrightGene
        7.22.1 BrightGene Details
        7.22.2 BrightGene Major Business
        7.22.3 BrightGene Factor Xa Inhibitors Product and Services
        7.22.4 BrightGene Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.22.5 BrightGene Recent Developments/Updates
        7.22.6 BrightGene Competitive Strengths & Weaknesses
    7.23 Kelun Pharmaceutical
        7.23.1 Kelun Pharmaceutical Details
        7.23.2 Kelun Pharmaceutical Major Business
        7.23.3 Kelun Pharmaceutical Factor Xa Inhibitors Product and Services
        7.23.4 Kelun Pharmaceutical Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.23.5 Kelun Pharmaceutical Recent Developments/Updates
        7.23.6 Kelun Pharmaceutical Competitive Strengths & Weaknesses
    7.24 Nanjing King-Friend Biochemical Pharmaceutical
        7.24.1 Nanjing King-Friend Biochemical Pharmaceutical Details
        7.24.2 Nanjing King-Friend Biochemical Pharmaceutical Major Business
        7.24.3 Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Product and Services
        7.24.4 Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.24.5 Nanjing King-Friend Biochemical Pharmaceutical Recent Developments/Updates
        7.24.6 Nanjing King-Friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Factor Xa Inhibitors Industry Chain
    8.2 Factor Xa Inhibitors Upstream Analysis
        8.2.1 Factor Xa Inhibitors Core Raw Materials
        8.2.2 Main Manufacturers of Factor Xa Inhibitors Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Factor Xa Inhibitors Production Mode
    8.6 Factor Xa Inhibitors Procurement Model
    8.7 Factor Xa Inhibitors Industry Sales Model and Sales Channels
        8.7.1 Factor Xa Inhibitors Sales Model
        8.7.2 Factor Xa Inhibitors Typical Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. World Factor Xa Inhibitors Production Value by Region (2019, 2023 and 2030) & (USD Million)
 Table 2. World Factor Xa Inhibitors Production Value by Region (2019-2024) & (USD Million)
 Table 3. World Factor Xa Inhibitors Production Value by Region (2025-2030) & (USD Million)
 Table 4. World Factor Xa Inhibitors Production Value Market Share by Region (2019-2024)
 Table 5. World Factor Xa Inhibitors Production Value Market Share by Region (2025-2030)
 Table 6. World Factor Xa Inhibitors Production by Region (2019-2024) & (K Units)
 Table 7. World Factor Xa Inhibitors Production by Region (2025-2030) & (K Units)
 Table 8. World Factor Xa Inhibitors Production Market Share by Region (2019-2024)
 Table 9. World Factor Xa Inhibitors Production Market Share by Region (2025-2030)
 Table 10. World Factor Xa Inhibitors Average Price by Region (2019-2024) & (US$/Unit)
 Table 11. World Factor Xa Inhibitors Average Price by Region (2025-2030) & (US$/Unit)
 Table 12. Factor Xa Inhibitors Major Market Trends
 Table 13. World Factor Xa Inhibitors Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
 Table 14. World Factor Xa Inhibitors Consumption by Region (2019-2024) & (K Units)
 Table 15. World Factor Xa Inhibitors Consumption Forecast by Region (2025-2030) & (K Units)
 Table 16. World Factor Xa Inhibitors Production Value by Manufacturer (2019-2024) & (USD Million)
 Table 17. Production Value Market Share of Key Factor Xa Inhibitors Producers in 2023
 Table 18. World Factor Xa Inhibitors Production by Manufacturer (2019-2024) & (K Units)
 Table 19. Production Market Share of Key Factor Xa Inhibitors Producers in 2023
 Table 20. World Factor Xa Inhibitors Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 21. Global Factor Xa Inhibitors Company Evaluation Quadrant
 Table 22. World Factor Xa Inhibitors Industry Rank of Major Manufacturers, Based on Production Value in 2023
 Table 23. Head Office and Factor Xa Inhibitors Production Site of Key Manufacturer
 Table 24. Factor Xa Inhibitors Market: Company Product Type Footprint
 Table 25. Factor Xa Inhibitors Market: Company Product Application Footprint
 Table 26. Factor Xa Inhibitors Competitive Factors
 Table 27. Factor Xa Inhibitors New Entrant and Capacity Expansion Plans
 Table 28. Factor Xa Inhibitors Mergers & Acquisitions Activity
 Table 29. United States VS China Factor Xa Inhibitors Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
 Table 30. United States VS China Factor Xa Inhibitors Production Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 31. United States VS China Factor Xa Inhibitors Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
 Table 32. United States Based Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (States, Country)
 Table 33. United States Based Manufacturers Factor Xa Inhibitors Production Value, (2019-2024) & (USD Million)
 Table 34. United States Based Manufacturers Factor Xa Inhibitors Production Value Market Share (2019-2024)
 Table 35. United States Based Manufacturers Factor Xa Inhibitors Production (2019-2024) & (K Units)
 Table 36. United States Based Manufacturers Factor Xa Inhibitors Production Market Share (2019-2024)
 Table 37. China Based Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (Province, Country)
 Table 38. China Based Manufacturers Factor Xa Inhibitors Production Value, (2019-2024) & (USD Million)
 Table 39. China Based Manufacturers Factor Xa Inhibitors Production Value Market Share (2019-2024)
 Table 40. China Based Manufacturers Factor Xa Inhibitors Production, (2019-2024) & (K Units)
 Table 41. China Based Manufacturers Factor Xa Inhibitors Production Market Share (2019-2024)
 Table 42. Rest of World Based Factor Xa Inhibitors Manufacturers, Headquarters and Production Site (State, Country)
 Table 43. Rest of World Based Manufacturers Factor Xa Inhibitors Production Value, (2019-2024) & (USD Million)
 Table 44. Rest of World Based Manufacturers Factor Xa Inhibitors Production Value Market Share (2019-2024)
 Table 45. Rest of World Based Manufacturers Factor Xa Inhibitors Production, (2019-2024) & (K Units)
 Table 46. Rest of World Based Manufacturers Factor Xa Inhibitors Production Market Share (2019-2024)
 Table 47. World Factor Xa Inhibitors Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 48. World Factor Xa Inhibitors Production by Type (2019-2024) & (K Units)
 Table 49. World Factor Xa Inhibitors Production by Type (2025-2030) & (K Units)
 Table 50. World Factor Xa Inhibitors Production Value by Type (2019-2024) & (USD Million)
 Table 51. World Factor Xa Inhibitors Production Value by Type (2025-2030) & (USD Million)
 Table 52. World Factor Xa Inhibitors Average Price by Type (2019-2024) & (US$/Unit)
 Table 53. World Factor Xa Inhibitors Average Price by Type (2025-2030) & (US$/Unit)
 Table 54. World Factor Xa Inhibitors Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 55. World Factor Xa Inhibitors Production by Application (2019-2024) & (K Units)
 Table 56. World Factor Xa Inhibitors Production by Application (2025-2030) & (K Units)
 Table 57. World Factor Xa Inhibitors Production Value by Application (2019-2024) & (USD Million)
 Table 58. World Factor Xa Inhibitors Production Value by Application (2025-2030) & (USD Million)
 Table 59. World Factor Xa Inhibitors Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. World Factor Xa Inhibitors Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
 Table 62. Pfizer Major Business
 Table 63. Pfizer Factor Xa Inhibitors Product and Services
 Table 64. Pfizer Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 65. Pfizer Recent Developments/Updates
 Table 66. Pfizer Competitive Strengths & Weaknesses
 Table 67. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
 Table 68. Bristol Myers Squibb Major Business
 Table 69. Bristol Myers Squibb Factor Xa Inhibitors Product and Services
 Table 70. Bristol Myers Squibb Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 71. Bristol Myers Squibb Recent Developments/Updates
 Table 72. Bristol Myers Squibb Competitive Strengths & Weaknesses
 Table 73. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
 Table 74. Daiichi Sankyo Major Business
 Table 75. Daiichi Sankyo Factor Xa Inhibitors Product and Services
 Table 76. Daiichi Sankyo Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. Daiichi Sankyo Recent Developments/Updates
 Table 78. Daiichi Sankyo Competitive Strengths & Weaknesses
 Table 79. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 80. Janssen Pharmaceuticals Major Business
 Table 81. Janssen Pharmaceuticals Factor Xa Inhibitors Product and Services
 Table 82. Janssen Pharmaceuticals Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 83. Janssen Pharmaceuticals Recent Developments/Updates
 Table 84. Janssen Pharmaceuticals Competitive Strengths & Weaknesses
 Table 85. Bayer Basic Information, Manufacturing Base and Competitors
 Table 86. Bayer Major Business
 Table 87. Bayer Factor Xa Inhibitors Product and Services
 Table 88. Bayer Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 89. Bayer Recent Developments/Updates
 Table 90. Bayer Competitive Strengths & Weaknesses
 Table 91. Viatris Basic Information, Manufacturing Base and Competitors
 Table 92. Viatris Major Business
 Table 93. Viatris Factor Xa Inhibitors Product and Services
 Table 94. Viatris Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 95. Viatris Recent Developments/Updates
 Table 96. Viatris Competitive Strengths & Weaknesses
 Table 97. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
 Table 98. Dr. Reddy's Laboratories Major Business
 Table 99. Dr. Reddy's Laboratories Factor Xa Inhibitors Product and Services
 Table 100. Dr. Reddy's Laboratories Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 101. Dr. Reddy's Laboratories Recent Developments/Updates
 Table 102. Dr. Reddy's Laboratories Competitive Strengths & Weaknesses
 Table 103. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
 Table 104. GlaxoSmithKline Major Business
 Table 105. GlaxoSmithKline Factor Xa Inhibitors Product and Services
 Table 106. GlaxoSmithKline Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 107. GlaxoSmithKline Recent Developments/Updates
 Table 108. GlaxoSmithKline Competitive Strengths & Weaknesses
 Table 109. Eugia Pharma Basic Information, Manufacturing Base and Competitors
 Table 110. Eugia Pharma Major Business
 Table 111. Eugia Pharma Factor Xa Inhibitors Product and Services
 Table 112. Eugia Pharma Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 113. Eugia Pharma Recent Developments/Updates
 Table 114. Eugia Pharma Competitive Strengths & Weaknesses
 Table 115. Accord Healthcare Basic Information, Manufacturing Base and Competitors
 Table 116. Accord Healthcare Major Business
 Table 117. Accord Healthcare Factor Xa Inhibitors Product and Services
 Table 118. Accord Healthcare Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 119. Accord Healthcare Recent Developments/Updates
 Table 120. Accord Healthcare Competitive Strengths & Weaknesses
 Table 121. Apotex Basic Information, Manufacturing Base and Competitors
 Table 122. Apotex Major Business
 Table 123. Apotex Factor Xa Inhibitors Product and Services
 Table 124. Apotex Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 125. Apotex Recent Developments/Updates
 Table 126. Apotex Competitive Strengths & Weaknesses
 Table 127. Zydus Basic Information, Manufacturing Base and Competitors
 Table 128. Zydus Major Business
 Table 129. Zydus Factor Xa Inhibitors Product and Services
 Table 130. Zydus Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 131. Zydus Recent Developments/Updates
 Table 132. Zydus Competitive Strengths & Weaknesses
 Table 133. Lupin Basic Information, Manufacturing Base and Competitors
 Table 134. Lupin Major Business
 Table 135. Lupin Factor Xa Inhibitors Product and Services
 Table 136. Lupin Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 137. Lupin Recent Developments/Updates
 Table 138. Lupin Competitive Strengths & Weaknesses
 Table 139. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 140. Jiangsu Hengrui Pharmaceuticals Major Business
 Table 141. Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Product and Services
 Table 142. Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 143. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
 Table 144. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
 Table 145. Cspc Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 146. Cspc Ouyi Pharmaceutical Major Business
 Table 147. Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Product and Services
 Table 148. Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 149. Cspc Ouyi Pharmaceutical Recent Developments/Updates
 Table 150. Cspc Ouyi Pharmaceutical Competitive Strengths & Weaknesses
 Table 151. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 152. Zhejiang Hisun Pharmaceutical Major Business
 Table 153. Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Product and Services
 Table 154. Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 155. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
 Table 156. Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses
 Table 157. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
 Table 158. Hansoh Pharma Major Business
 Table 159. Hansoh Pharma Factor Xa Inhibitors Product and Services
 Table 160. Hansoh Pharma Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 161. Hansoh Pharma Recent Developments/Updates
 Table 162. Hansoh Pharma Competitive Strengths & Weaknesses
 Table 163. Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 164. Chia Tai Tianqing Pharmaceutical Major Business
 Table 165. Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Product and Services
 Table 166. Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 167. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
 Table 168. Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
 Table 169. Shanghai Huilun Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 170. Shanghai Huilun Pharmaceutical Major Business
 Table 171. Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Product and Services
 Table 172. Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 173. Shanghai Huilun Pharmaceutical Recent Developments/Updates
 Table 174. Shanghai Huilun Pharmaceutical Competitive Strengths & Weaknesses
 Table 175. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 176. Qilu Pharmaceutical Major Business
 Table 177. Qilu Pharmaceutical Factor Xa Inhibitors Product and Services
 Table 178. Qilu Pharmaceutical Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 179. Qilu Pharmaceutical Recent Developments/Updates
 Table 180. Qilu Pharmaceutical Competitive Strengths & Weaknesses
 Table 181. HEC Pharma Basic Information, Manufacturing Base and Competitors
 Table 182. HEC Pharma Major Business
 Table 183. HEC Pharma Factor Xa Inhibitors Product and Services
 Table 184. HEC Pharma Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 185. HEC Pharma Recent Developments/Updates
 Table 186. HEC Pharma Competitive Strengths & Weaknesses
 Table 187. BrightGene Basic Information, Manufacturing Base and Competitors
 Table 188. BrightGene Major Business
 Table 189. BrightGene Factor Xa Inhibitors Product and Services
 Table 190. BrightGene Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 191. BrightGene Recent Developments/Updates
 Table 192. BrightGene Competitive Strengths & Weaknesses
 Table 193. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 194. Kelun Pharmaceutical Major Business
 Table 195. Kelun Pharmaceutical Factor Xa Inhibitors Product and Services
 Table 196. Kelun Pharmaceutical Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 197. Kelun Pharmaceutical Recent Developments/Updates
 Table 198. Kelun Pharmaceutical Competitive Strengths & Weaknesses
 Table 199. Nanjing King-Friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
 Table 200. Nanjing King-Friend Biochemical Pharmaceutical Major Business
 Table 201. Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Product and Services
 Table 202. Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
 Table 203. Nanjing King-Friend Biochemical Pharmaceutical Recent Developments/Updates
 Table 204. Nanjing King-Friend Biochemical Pharmaceutical Competitive Strengths & Weaknesses
 Table 205. Global Key Players of Factor Xa Inhibitors Upstream (Raw Materials)
 Table 206. Global Factor Xa Inhibitors Typical Customers
 Table 207. Factor Xa Inhibitors Typical Distributors


List of Figures
 Figure 1. Factor Xa Inhibitors Picture
 Figure 2. World Factor Xa Inhibitors Production Value: 2019 & 2023 & 2030, (USD Million)
 Figure 3. World Factor Xa Inhibitors Production Value and Forecast (2019-2030) & (USD Million)
 Figure 4. World Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 5. World Factor Xa Inhibitors Average Price (2019-2030) & (US$/Unit)
 Figure 6. World Factor Xa Inhibitors Production Value Market Share by Region (2019-2030)
 Figure 7. World Factor Xa Inhibitors Production Market Share by Region (2019-2030)
 Figure 8. North America Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 9. Europe Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 10. China Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 11. Japan Factor Xa Inhibitors Production (2019-2030) & (K Units)
 Figure 12. Factor Xa Inhibitors Market Drivers
 Figure 13. Factors Affecting Demand
 Figure 14. World Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 15. World Factor Xa Inhibitors Consumption Market Share by Region (2019-2030)
 Figure 16. United States Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 17. China Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 18. Europe Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 19. Japan Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 20. South Korea Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 21. ASEAN Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 22. India Factor Xa Inhibitors Consumption (2019-2030) & (K Units)
 Figure 23. Producer Shipments of Factor Xa Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2023
 Figure 24. Global Four-firm Concentration Ratios (CR4) for Factor Xa Inhibitors Markets in 2023
 Figure 25. Global Four-firm Concentration Ratios (CR8) for Factor Xa Inhibitors Markets in 2023
 Figure 26. United States VS China: Factor Xa Inhibitors Production Value Market Share Comparison (2019 & 2023 & 2030)
 Figure 27. United States VS China: Factor Xa Inhibitors Production Market Share Comparison (2019 & 2023 & 2030)
 Figure 28. United States VS China: Factor Xa Inhibitors Consumption Market Share Comparison (2019 & 2023 & 2030)
 Figure 29. United States Based Manufacturers Factor Xa Inhibitors Production Market Share 2023
 Figure 30. China Based Manufacturers Factor Xa Inhibitors Production Market Share 2023
 Figure 31. Rest of World Based Manufacturers Factor Xa Inhibitors Production Market Share 2023
 Figure 32. World Factor Xa Inhibitors Production Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 33. World Factor Xa Inhibitors Production Value Market Share by Type in 2023
 Figure 34. Oral Drugs
 Figure 35. Injections
 Figure 36. World Factor Xa Inhibitors Production Market Share by Type (2019-2030)
 Figure 37. World Factor Xa Inhibitors Production Value Market Share by Type (2019-2030)
 Figure 38. World Factor Xa Inhibitors Average Price by Type (2019-2030) & (US$/Unit)
 Figure 39. World Factor Xa Inhibitors Production Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 40. World Factor Xa Inhibitors Production Value Market Share by Application in 2023
 Figure 41. Deep Vein Thrombosis
 Figure 42. Pulmonary Embolism
 Figure 43. Atrial Fibrillation
 Figure 44. Other
 Figure 45. World Factor Xa Inhibitors Production Market Share by Application (2019-2030)
 Figure 46. World Factor Xa Inhibitors Production Value Market Share by Application (2019-2030)
 Figure 47. World Factor Xa Inhibitors Average Price by Application (2019-2030) & (US$/Unit)
 Figure 48. Factor Xa Inhibitors Industry Chain
 Figure 49. Factor Xa Inhibitors Procurement Model
 Figure 50. Factor Xa Inhibitors Sales Model
 Figure 51. Factor Xa Inhibitors Sales Channels, Direct Sales, and Distribution
 Figure 52. Methodology
 Figure 53. Research Process and Data Source

Companies Mentioned

Pfizer
Bristol Myers Squibb
Daiichi Sankyo
Janssen Pharmaceuticals
Bayer
Viatris
Dr. Reddy's Laboratories
GlaxoSmithKline
Eugia Pharma
Accord Healthcare
Apotex
Zydus
Lupin
Jiangsu Hengrui Pharmaceuticals
Cspc Ouyi Pharmaceutical
Zhejiang Hisun Pharmaceutical
Hansoh Pharma
Chia Tai Tianqing Pharmaceutical
Shanghai Huilun Pharmaceutical
Qilu Pharmaceutical
HEC Pharma
BrightGene
Kelun Pharmaceutical
Nanjing King-Friend Biochemical Pharmaceutical